MY113497A - Peptides and compounds that bind to a receptor - Google Patents
Peptides and compounds that bind to a receptorInfo
- Publication number
- MY113497A MY113497A MYPI96002267A MYPI19962267A MY113497A MY 113497 A MY113497 A MY 113497A MY PI96002267 A MYPI96002267 A MY PI96002267A MY PI19962267 A MYPI19962267 A MY PI19962267A MY 113497 A MY113497 A MY 113497A
- Authority
- MY
- Malaysia
- Prior art keywords
- peptides
- bind
- peptide mimetics
- receptor
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
DESCRIBED ARE PEPTIDES AND PEPTIDE MIMETICS THAT BIND TO AND ACTIVATE THE THROMBOPOIETIN RECEPTOR. SUCH PEPTIDES AND PEPTIDE MIMETICS ARE USEFUL IN METHODS FOR TREATING HEMATOLOGICAL DISORDERS AND PARTICULARLY, THROMBOCYTOPENIA RESULTING FROM CHEMOTHERAPY, RADIATION THERAPY, OR BONE MARROW TRANSFUSIONS AS''WELL AS IN DIAGNOSTIC METHODS EMPLOYING LABELED PEPTIDES AND PEPTIDE MIMETICS.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47360495A | 1995-06-07 | 1995-06-07 | |
US48530195A | 1995-06-07 | 1995-06-07 | |
US48409095A | 1995-06-07 | 1995-06-07 | |
US47237195A | 1995-06-07 | 1995-06-07 | |
US47616895A | 1995-06-07 | 1995-06-07 | |
US47812895A | 1995-06-07 | 1995-06-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
MY113497A true MY113497A (en) | 2002-03-30 |
Family
ID=27560032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI96002267A MY113497A (en) | 1995-06-07 | 1996-06-06 | Peptides and compounds that bind to a receptor |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU6046696A (en) |
HR (1) | HRP960256A2 (en) |
MY (1) | MY113497A (en) |
WO (1) | WO1996040189A1 (en) |
YU (1) | YU34196A (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7091311B2 (en) | 1996-06-07 | 2006-08-15 | Smithkline Beecham Corporation | Peptides and compounds that bind to a receptor |
US6121416A (en) | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
US20030069177A1 (en) | 2000-05-16 | 2003-04-10 | Genentech, Inc. | Method for treating cartilage disorders |
US6420518B1 (en) | 1997-04-04 | 2002-07-16 | Genetech, Inc. | Insulin-like growth factor agonist molecules |
CN1810832B (en) | 1998-10-23 | 2012-12-12 | 麒麟-安姆根有限公司 | Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
JP4937435B2 (en) | 1998-11-05 | 2012-05-23 | 修一 広野 | Novel compounds and their pharmaceutical uses |
CA2355163A1 (en) * | 1998-12-18 | 2000-06-29 | Mount Sinai Hospital | Three dimensional structure of a sterile alpha motif domain |
EP1141014B1 (en) | 1999-01-06 | 2004-12-08 | Genentech, Inc. | Insulin-like growth factor (igf) i mutant variant |
WO2001010891A2 (en) * | 1999-08-05 | 2001-02-15 | Research Corporation Technologies, Inc. | Il-16 antagonists |
EP1149906A1 (en) * | 2000-04-25 | 2001-10-31 | Pliva, Farmaceutska, Industrija, Dionicko Drustvo | Thrombopoietin receptor modulating peptide |
US7396917B2 (en) | 2000-12-05 | 2008-07-08 | Alexion Pharmaceuticals, Inc. | Rationally designed antibodies |
ES2258558T3 (en) * | 2000-12-05 | 2006-09-01 | Alexion Pharmaceuticals, Inc. | RATIONALALLY DESIGNED ANTIBODIES. |
JP2004532203A (en) * | 2001-03-21 | 2004-10-21 | ザ、ユニバーシティ、オブ、テキサス、システム | Glycosaminoglycan inhibitors |
US7332474B2 (en) | 2001-10-11 | 2008-02-19 | Amgen Inc. | Peptides and related compounds having thrombopoietic activity |
CA2495184A1 (en) | 2002-08-14 | 2004-02-26 | Nissan Chemical Industries, Ltd. | Thrombopoietin receptor activators and process for their production |
MXPA05003057A (en) | 2002-09-18 | 2006-04-18 | Johnson & Johnson | Methods of increasing platelet and hematopoietic stem cell production. |
TWI324593B (en) | 2002-10-09 | 2010-05-11 | Nissan Chemical Ind Ltd | Pyrazolone compounds and thrombopoietin receptor activator |
EP1628686A2 (en) | 2003-05-12 | 2006-03-01 | Affymax, Inc. | Spacer moiety for poly (ethylene glycol)-modified peptides |
SI1629007T1 (en) | 2003-05-12 | 2009-10-31 | Affymax Inc | Novel peptides that bind to the erythropoietin receptor |
WO2004101611A2 (en) | 2003-05-12 | 2004-11-25 | Affymax, Inc. | Peptides that bind to the erythropoietin receptor |
CA2588979C (en) | 2004-12-08 | 2013-01-22 | Nissan Chemical Industries, Ltd. | 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
RU2401259C2 (en) | 2004-12-14 | 2010-10-10 | Ниссан Кемикал Индастриз, ЛТД | Amide compounds and thrombopoietin receptor activators |
US7550433B2 (en) | 2005-06-03 | 2009-06-23 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
JP5071375B2 (en) | 2005-07-15 | 2012-11-14 | 日産化学工業株式会社 | Thiophene compound and thrombopoietin receptor activator |
KR101290484B1 (en) | 2005-07-20 | 2013-07-26 | 닛산 가가쿠 고교 가부시키 가이샤 | Pyrazole compounds and thrombopoietin receptor activators |
JP5205967B2 (en) | 2005-11-07 | 2013-06-05 | 日産化学工業株式会社 | Hydrazide compounds and thrombopoietin receptor activators |
WO2007142308A1 (en) | 2006-06-07 | 2007-12-13 | Nissan Chemical Industries, Ltd. | Nitrogen-containing heterocyclic compound and thrombopoietin receptor activator |
US7981425B2 (en) | 2006-06-19 | 2011-07-19 | Amgen Inc. | Thrombopoietic compounds |
EP1897888A1 (en) * | 2006-09-05 | 2008-03-12 | AplaGen GmbH | Peptides binding the TPO receptor |
WO2008028645A1 (en) * | 2006-09-05 | 2008-03-13 | Aplagen Gmbh | Peptides binding the tpo receptor |
EP2118127A4 (en) | 2007-01-31 | 2010-12-01 | Affymax Inc | Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules |
WO2009029682A1 (en) * | 2007-08-28 | 2009-03-05 | Rigel Pharmaceuticals, Inc. | Combination therapy with syk kinase inhibitor |
US8889732B2 (en) | 2009-10-23 | 2014-11-18 | Nissan Chemical Industries, Ltd. | Fused heterocyclic compounds and thrombopoietin receptor activators |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5198424A (en) * | 1989-03-08 | 1993-03-30 | Board Of Regents Of The University Of Oklahoma | Functionally active selectin-derived peptides |
-
1996
- 1996-06-05 WO PCT/US1996/008998 patent/WO1996040189A1/en active Application Filing
- 1996-06-05 YU YU34196A patent/YU34196A/en unknown
- 1996-06-05 AU AU60466/96A patent/AU6046696A/en not_active Abandoned
- 1996-06-06 MY MYPI96002267A patent/MY113497A/en unknown
- 1996-06-06 HR HR08/485,301A patent/HRP960256A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU6046696A (en) | 1996-12-30 |
WO1996040189A1 (en) | 1996-12-19 |
YU34196A (en) | 1999-03-04 |
HRP960256A2 (en) | 1998-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY113497A (en) | Peptides and compounds that bind to a receptor | |
MX9709315A (en) | Peptides and compounds that bind to a thrombopoietin receptor. | |
CA2274149A1 (en) | Peptides and compounds that bind to a receptor | |
BG104236A (en) | Transgenous mammals producing oligosaccharides in their milk | |
EP1194164B8 (en) | Prion protein peptides and uses thereof | |
UA29494C2 (en) | Humanized antibodies, methods for producing thereof, a method for treatment of Crohns disease, a method for treatment OF disseminated sclerosis, pharmaceutical composition | |
EP0724456A4 (en) | Antibodies to cd40 | |
AU2821195A (en) | Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin | |
MY116478A (en) | Tri-substituted imidazoles having multiple therapeutic properties | |
HK1021824A1 (en) | Compositions and methods for treating infections using analogues of indolicidin | |
GR3036906T3 (en) | Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof. | |
ZA944950B (en) | Protein purification | |
PL336470A1 (en) | Mammalian cytokin-like factor 7 | |
HK1014158A1 (en) | Anti-fungal methods and materials | |
AU1378395A (en) | Metal chelators | |
BG103872A (en) | Glycoconjugates of 20(s)-camptotecin | |
AU5892399A (en) | 1, 2, 4-triazole-3-thione compounds | |
WO1997045746A3 (en) | Prion protein binding proteins and uses thereof | |
EP1176201A3 (en) | Platelet-specific chimeric immunoglobulin | |
GB9509557D0 (en) | PCNA binding substance | |
UA72875C2 (en) | Novel proteins which bind human <sub>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-amyloid peptide, polynucleotides which encode theM | |
GR3033942T3 (en) | Method of identifying substances with a potential herbicidal or growth-regulatory action by means of vegetable transporter proteins, use of such transporter proteins for this purpose, and substances with a herbicidal or growth-regulatory action identified by the method | |
ZA966489B (en) | New protein human MP52 Arg. | |
GB2325466A (en) | Nucleotide sequence from goat liver | |
HU9600727D0 (en) | Triaryl-ethylene derivatives for use in therapy |